CytoD Overview

  • Founded
  • 2008
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

CytoD General Information


Provider of therapeutic services intended to offer a therapeutic approach to treat chronic asthma and rheumatoid arthritis of patients. The company's services focus on the pathways that restrict homing of specific subsets of immune cells to their activation sites in the lymph nodes and sites of inflammation, enabling patients to have a fine-tune of an immune response.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Therapeutic Devices
Primary Office
  • Tel-Hai Industrial Park
  • Tel Aviv 11013
  • Israel
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CytoD Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Jan-2012 Completed Out of Business
1. Early Stage VC Completed Startup
To view CytoD’s complete valuation and funding history, request access »